Full Press Release Details
8k_010721.
XCUR
8k_010721
Key Takeaway: 8k_010721
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+35%
120-day peak, hindsight
Typical move
19.3%
average across 2 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
GPC-100
Phase 2 · Multiple Myeloma